Insider · CIK 0001861684

Young Joseph R

Reports to the SEC for 1 company · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001861684

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-11	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+5,000 sh	$3.94	+$19.7K	80,754
2026-09-11	VERAVera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	−5,000 sh	—	—	33,589
2026-03-13	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+10K sh	$3.94	+$39.4K	75,754
2026-03-13	VERAVera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	−10K sh	—	—	38,589
2026-02-23	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−3,117 sh	$41.98	−$131K	64,722
2026-02-04	VERAVera Therapeutics, Inc.A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+10K sh	—	—	67,839
2026-02-04	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+20K sh	—	—	20,000
2025-11-13	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+10K sh	$3.94	+$39.4K	57,839
2025-11-13	VERAVera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	−10K sh	—	—	48,589
2025-11-11	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−15K sh	$29.06	−$436K	47,839
2025-02-18	VERAVera Therapeutics, Inc.A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+10.7K sh	—	—	61,946
2025-02-18	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+21.5K sh	—	—	21,500
2024-05-16	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+18.2K sh	$7.87	+$143K	69,357
2024-05-16	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−18.2K sh	$42.22	−$766K	51,206
2024-05-16	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+2,500 sh	$7.87	+$19.7K	53,706
2024-05-16	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−2,500 sh	$43.03	−$108K	51,206
2024-05-16	VERAVera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	−20.7K sh	—	—	69,349
2024-05-15	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+8,221 sh	$3.94	+$32.4K	61,392
2024-05-15	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−8,221 sh	$42.17	−$347K	53,171
2024-05-15	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−1,965 sh	$42.68	−$83.9K	51,206
2024-05-15	VERAVera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	−8,221 sh	—	—	58,589
2024-04-10	VERAVera Therapeutics, Inc.S Sale	SVP, FINANCE, CHIEF ACCT OFFCR	SSale	−5,714 sh	$40.00	−$229K	53,171
2024-01-16	VERAVera Therapeutics, Inc.A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+21.9K sh	—	—	57,054
2024-01-16	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+81.3K sh	—	—	81,250
2023-07-05	VERAVera Therapeutics, Inc.M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	+10K sh	$3.94	+$39.4K	32,679
2023-07-05	VERAVera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, FINANCE, CHIEF ACCT OFFCR	MExercise/Conversion	−10K sh	—	—	66,810
2023-02-15	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+90K sh	—	—	90,000
2023-02-06	VERAVera Therapeutics, Inc.P Purchase	SVP, FINANCE, CHIEF ACCT OFFCR	PPurchase	+5,714 sh	$7.00	+$40K	22,679
2022-08-19	VERAVera Therapeutics, Inc.A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+15K sh	—	—	16,148
2022-02-16	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+36.7K sh	—	—	36,729
2022-02-06	VERAVera Therapeutics, Inc.P Purchase	SVP, FINANCE, CHIEF ACCT OFFCR	PPurchase	+5,714 sh	$7.00	+$40K	22,679
2021-05-13	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, FINANCE, CHIEF ACCT OFFCR	AAward	+13.7K sh	—	—	13,722

Recent filings

Accepted (ET)
Sep 144
Young Joseph R0001861684-26-000006
SEC(opens sec.gov)
Mar 164
Young Joseph R0001861684-26-000005
SEC(opens sec.gov)
Feb 254
Young Joseph R0001861684-26-000004
SEC(opens sec.gov)
Feb 64
Young Joseph R0001861684-26-000002
SEC(opens sec.gov)
Nov 134
Young Joseph R0001193125-25-280792
SEC(opens sec.gov)
Feb 204
Young Joseph R0001415889-25-004851
SEC(opens sec.gov)
May 174
Young Joseph R0001415889-24-013504
SEC(opens sec.gov)

Companies

Vera Therapeutics, Inc.SVP, FINANCE, CHIEF ACCT OFFCRVERA

Address

C/O VERA THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 1200

BRISBANE, CA, 94005